(S1 (S (S (NP (NP (NNS Transporters)) (, ,) (NP (NNS enzymes)) (, ,) (CC and) (NP (NN enalapril) (NN removal))) (PP (IN in) (NP (DT a) (NN rat) (-LRB- -LRB-) (JJ CC531-induced) (-RRB- -RRB-) (NN liver) (JJ metastatic) (NN model)))) (. .)))
(S1 (S (S (NP (NP (JJ Temporal) (NNS changes)) (PP (IN in) (NP (NP (JJ physiological) (NNS spaces)) (, ,) (NP (NP (NN protein) (NN expression)) (PP (IN of) (NP (NP (NNS transporters)) (CC and) (NP (NNS enzymes))))) (, ,) (CC and) (NP (NN enalapril) (NN removal))))) (VP (VBD were) (VP (VBN appraised) (PP (IN in) (NP (NP (DT the) (JJ metastatic) (NN liver) (NN tumor) (NN model)) (VP (VBN developed) (PP (IN from) (NP (JJ male) (NN Wag/Rij) (NNS rats))) (PP (IN after) (NP (NP (DT the) (JJ intraportal) (NN injection)) (PP (IN of) (NP (NN CC531) (NN colon) (NN adenocarcinoma) (NNS cells))))))))))) (: ;) (S (NP (JJ sham-operated) (NNS preparations)) (VP (VBD received) (NP (NN PBS)))) (. .)))
(S1 (S (S (NP (NP (NN Liver) (NN tissue) (NNS spaces)) (, ,) (VP (VBN investigated) (PP (IN with) (NP (JJ multiple) (NN indicator) (NN dilution) (NN technique))) (PP (IN in) (NP (NN liver) (NN perfusion) (NNS studies)))) (, ,)) (VP (VBD were) (ADJP (JJ unchanged)) (PP (IN at) (NP (NN week) (CD 3))) (PP (IN after) (NP (NN tumor) (NN induction))))) (. .)))
(S1 (S (S (PP (IN At) (NP (NN week) (CD 4))) (, ,) (ADVP (RB however)) (, ,) (NP (NP (NP (DT the) (JJ sinusoidal) (NN blood) (NN volume)) (CC and) (NP (NN albumin) (NN Disse) (NN space))) (PP (IN in) (NP (JJ tumor-bearing) (NNS livers)))) (VP (VBD were) (ADJP (RB slightly) (JJR lower)) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NN shams)))))))) (. .)))
(S1 (S (S (NP (NP (NP (VBN Increased) (NNS levels)) (PP (IN of) (NP (NP (DT the) (JJ canalicular) (NN ATP) (NNS transporters)) (, ,) (NP (NN P-glycoprotein)) (, ,) (NP (NP (JJ multidrug) (JJ resistance-associated) (NN protein) (CD 2)) (PRN (-LRB- -LRB-) (NP (NN Mrp2)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ bile) (NN salt) (NN export) (NN pump)))) (PRN (-LRB- -LRB-) (NP (NN Bsep)) (-RRB- -RRB-))) (PP (IN at) (NP (NN week) (CD 2))) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-)) (, ,) (NP (NP (JJ unchanged) (NNS levels)) (PP (IN of) (NP (NN Ntcp)))) (, ,) (NP (NN Oatp1a1)) (, ,) (NP (NNP Oatp1a4)) (, ,) (CC and) (NP (NN Mct2)) (, ,) (CC but) (NP (NP (NP (NP (VBN decreased) (NNS levels)) (PP (IN of) (NP (NP (NN cytochrome) (NN P450) (NN 3a2)) (PRN (-LRB- -LRB-) (NP (NN Cyp3a2)) (-RRB- -RRB-))))) (CC and) (NP (NP (NP (NN glutathione) (NN S-transferase)) (PRN (-LRB- -LRB-) (NP (NN Gst4-4)) (-RRB- -RRB-))) (PP (IN at) (NP (NN week) (CD 4))))) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (ADJP (ADJP (JJ peritumor)) (CC vs.) (ADJP (JJ sham-operated))) (NN liver) (NNS tissues))) (PP (IN with) (NP (NN Western) (NN blotting)))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ steady-state) (NN extraction) (NN ratio)) (PP (IN of) (NP (NP (NN enalapril)) (, ,) (NP (NP (DT a) (NN substrate)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ enters) (NP (DT the) (NN liver)) (ADVP (RB rapidly)) (PP (IN via) (NP (NN Oatp1a1)))) (CC and) (ADVP (RB primarily)) (VP (VBZ undergoes) (NP (NP (NN metabolism)) (PP (IN by) (NP (DT the) (NNS carboxylesterases))))))))) (, ,)))) (VP (VBD was) (VP (VBN unaffected) (PP (IN by) (NP (NN liver) (NN metastasis))) (PP (IN at) (NP (NN week) (CD 4))) (ADVP (RB regardless) (PP (IN of) (NP (NP (PRP$ its) (NN delivery)) (PP (IN via) (NP (NP (DT the) (JJ portal) (NN vein)) (CC or) (NP (JJ hepatic) (NN artery)))) (PP (IN into) (NP (DT the) (JJ perfused) (NN liver) (NNS preparations))))))))) (. .)))
